Actuate Therapeutics ACTU Cash Flow Statement (2023-2026)

NASDAQ ACTU
$0.70 +0.01 (+2.04%)
As of: Sep 30, 2026 · 10:14 AM EDT
Reported Financials

Actuate Therapeutics Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Actuate Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 12 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Share-based Compensation 0.16M0.12M0.15M0.09M0.57M1.19M1.13M1.58M1.80M1.54M1.34M
Cash from Operations -5.64M-5.51M-5.25M-2.67M-9.15M-4.77M-4.62M-4.17M-6.68M-3.74M
Change in Working Capital
Change in Account Payables 0.22M0.86M0.48M1.93M-3.61M-0.30M0.62M0.51M-1.83M0.19M
Change in Accured Expenses 0.48M0.79M1.96M0.81M0.10M-0.17M-0.72M-0.63M-0.31M-0.69M
Other Working Capital Changes 0.00M0.01M0.08M0.08M0.54M-0.17M-0.21M-0.16M0.32M-0.04M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 4.50M1.00M
Change in Capital Stock
Net Equity Issued and Repurchased 23.96M-0.03M
Misc.
Cash from Financing Activities 4.36M0.96M22.32M-0.11M-0.13M6.78M17.11M-0.03M
Change in Cash -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M
Free Cash Flow -5.64M-5.51M-5.25M-2.67M-9.15M-4.77M-4.62M-4.17M-6.68M-3.74M
Net Cash Flow -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M

Actuate Therapeutics Cash Flow Statement API

Pull Actuate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACTU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY